undamentalytics Newsletter
Sign in

Prestige Consumer Healthcare Inc. cash flow statement

In fiscal 2026, Prestige Consumer Healthcare Inc.'s operations generated $258m of cash; it spent $11.2m on capital projects, leaving free cash flow of $246m. It returned $156m through buybacks.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2010Mar 20102011Mar 20112012Mar 20122013Mar 20132014Mar 20142015Mar 20152016Mar 20162017Mar 20172018Mar 20182019Mar 20192020Mar 20202021Mar 20212022Mar 20222023Mar 20232024Mar 20242025Mar 20252026Mar 2026LTMJun 2026
Cash from operations598767138112156176149210189217236260230249252258249
Depreciation and amortisation111011131318242633322930323331303132
Stock-based pay243457108978991214111111
Capital spending111103643131015221081081114
Free cash flow598667127109150173146198179203213250222239243246235
Free cash flow after stock pay578264124104143163138189171195205241210225232236224
Dividends paid———0000———————————
Share buybacks———————005057120502552156122

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: PBH vs TRLVANIP vs PBHHRMY vs PBH

More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies

Figures from Prestige Consumer Healthcare Inc.'s SEC filings (10-K and 10-Q), retrieved October 26, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Prestige Consumer Healthcare Inc.